NSTM has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NSTM has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
NovelStem International's Operating Income for the three months ended in Mar. 2024 was $-0.18 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2024 was $-3.00 Mil.
Warning Sign:
NovelStem International Corp had lost money in 92% of the time over the past 12quarters.
Operating Margin % is calculated as Operating Income divided by its Revenue. NovelStem International's Operating Income for the three months ended in Mar. 2024 was $-0.18 Mil. NovelStem International's Revenue for the three months ended in Mar. 2024 was $0.00 Mil. Therefore, NovelStem International's Operating Margin % for the quarter that ended in Mar. 2024 was -6,000.00%.
NovelStem International's 5-Year average Growth Rate for Operating Margin % was 0.00% per year.
Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. NovelStem International's annualized ROC % for the quarter that ended in Mar. 2024 was -18.26%. NovelStem International's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was %.
The historical data trend for NovelStem International's Operating Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NovelStem International Annual Data | |||||||||||||||||||||
Trend | Dec06 | Dec07 | Dec08 | Dec09 | Dec10 | Dec11 | Dec12 | Dec21 | Dec22 | Dec23 | |||||||||||
Operating Income | Get a 7-Day Free Trial | -5.81 | -5.70 | -0.50 | -0.73 | -0.65 |
NovelStem International Quarterly Data | ||||||||||||||||||||
Sep11 | Dec11 | Mar12 | Jun12 | Sep12 | Dec12 | Mar13 | Jun13 | Sep13 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Operating Income | Get a 7-Day Free Trial | -0.17 | -2.72 | -0.08 | -0.03 | -0.18 |
Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.
Operating Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.00 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NovelStem International (OTCPK:NSTM) Operating Income Explanation
1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.
NovelStem International's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:
ROC % (Q: Mar. 2024 ) | ||||||
= | NOPAT | / | Average Invested Capital | |||
= | Operating Income * ( 1 - Tax Rate % ) | / | ( (Invested Capital (Q: Dec. 2023 ) | + | Invested Capital (Q: Mar. 2024 )) | / count ) |
= | -0.72 * ( 1 - 0% ) | / | ( (2.418 | + | 5.466) | / 2 ) |
= | -0.72 | / | 3.942 | |||
= | -18.26 % |
where
Invested Capital | (Q: Dec. 2023 ) | |||||||||||
= | Total Assets | - | Accounts Payable & Accrued Expense | - | Excess Cash | |||||||
= | Total Assets | - | Accounts Payable & Accrued Expense | - | ( Cash, Cash Equivalents, Marketable Securities | - | max(0, Total Current Liabilities | - | Total Current Assets | + | Cash, Cash Equivalents, Marketable Securities | )) |
= | 2.255 | - | 0.096 | - | ( 0.053 | - | max(0, 0.346 | - | 0.087 | + | 0.053 | )) |
= | 2.418 |
Invested Capital | (Q: Mar. 2024 ) | |||||||||||
= | Total Assets | - | Accounts Payable & Accrued Expense | - | Excess Cash | |||||||
= | Total Assets | - | Accounts Payable & Accrued Expense | - | ( Cash, Cash Equivalents, Marketable Securities | - | max(0, Total Current Liabilities | - | Total Current Assets | + | Cash, Cash Equivalents, Marketable Securities | )) |
= | 2.401 | - | 0.196 | - | ( 0.005 | - | max(0, 3.297 | - | 0.036 | + | 0.005 | )) |
= | 5.466 |
Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.
2. Joel Greenblatt's definition of Return on Capital:
NovelStem International's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:
ROC (Joel Greenblatt) % | (Q: Mar. 2024 ) | ||||||
= | EBIT | / | Average of (Net fixed Assets | + | Net Working Capital) | ||
= | EBIT | / | Average of (Property, Plant and Equipment | + | Net Working Capital) | ||
Q: Dec. 2023 | Q: Mar. 2024 | ||||||
= | EBIT | / | ( ( (Property, Plant and Equipment + Net Working Capital) | + | (Property, Plant and Equipment + Net Working Capital) ) | / | count ) |
= | -0.62 | / | ( ( (0 + max(-0.062, 0)) | + | (0 + max(-0.165, 0)) ) | / | 2 ) |
= | -0.62 | / | ( ( 0 | + | 0 ) | / | 2 ) |
= | -0.62 | / | 0 | ||||
= | % |
where Working Capital is:
Working Capital | (Q: Dec. 2023 ) | ||||||||||
= | (Accounts Receivable | + | Total Inventories | + | Other Current Assets) | - | (Accounts Payable & Accrued Expense | + | Defer. Rev. | + | Other Current Liabilities) |
= | (0 | + | 0 | + | 0.034) | - | (0.096 | + | 0 | + | 0) |
= | -0.062 |
Working Capital | (Q: Mar. 2024 ) | ||||||||||
= | (Accounts Receivable | + | Total Inventories | + | Other Current Assets) | - | (Accounts Payable & Accrued Expense | + | Defer. Rev. | + | Other Current Liabilities) |
= | (0.003 | + | 0 | + | 0.028) | - | (0.196 | + | 0 | + | 0) |
= | -0.165 |
When net working capital is negative, 0 is used.
Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.
3. Operating Income is also linked to Operating Margin %:
NovelStem International's Operating Margin % for the quarter that ended in Mar. 2024 is calculated as:
Operating Margin % | = | Operating Income (Q: Mar. 2024 ) | / | Revenue (Q: Mar. 2024 ) |
= | -0.18 | / | 0.003 | |
= | -6,000.00 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.
Be Aware
Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Thank you for viewing the detailed overview of NovelStem International's Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Baker Street Capital Management, Llc | 10 percent owner | 1875 CENTURY PARK EAST, SUITE 700, LOS ANGELES CA 90067 |
Vadim Perelman | 10 percent owner | 1875 CENTURY PARK EAST, SUITE 700, LOS ANGELES CA 90067 |
Baker Street Capital L.p. | 10 percent owner | 1875 CENTURY PARK EAST, SUITE 700, LOS ANGELES CA 90067 |
Stephen Gans | director, 10 percent owner | 14850 NW 44TH COURT, OPA LOCKA FL 33054 |
Shannon River Partners Lp | 10 percent owner | 850 THIRD AVENUE, 13TH FLOOR, NEW YORK NY 10022 |
Shannon River Fund Management Co Llc | 10 percent owner | 850 THIRD AVENUE, 13TH FLOOR, NEW YORK NY 10022 |
Shannon River Partners Ii, Lp | 10 percent owner | 850 THIRD AVENUE, 13TH FLOOR, NEW YORK NY 10022 |
Doonbeg Fund Lp | 10 percent owner | 850 THIRD AVE, 13TH FLOOR, New York ny 10022 |
Spencer M. Waxman | director | C/O SHANNON RIVER PARTNERS, 800 THIRD AVENUE 30TH FLOOR, NEW YORK NY 10022 |
Stanley Morgan | 10 percent owner | 1585 BROADWAY, NEW YORK NY 10036 |
Robert D. Epstein | director | 2255 GLADES ROAD, BOCA RATON FL 33431 |
Coghill Capital Management Llc | 10 percent owner | 233 SOUTH WACKER DRIVE, SUITE 8439, CHICAGO IL 60606 |
Ccm Master Fund Ltd | 10 percent owner | C/O MORGAN STANLEY FUND SERVICES (CAYMAN, LTD CENTURY YARD CRICKET SQ HUTCHINGS DR, PO BOX 2681 GEORGE TOWN E9 00000 |
Clint D Coghill | 10 percent owner | |
Scott Gomez | officer: Chief Accounting Officer |
From GuruFocus
By PRNewswire PRNewswire • 07-16-2018
By gurufocus 10qk • 05-17-2010
By gurufocus 10qk • 04-30-2010
By gurufocus • 05-11-2009
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.